Report cover image

Global Nifedipine Controlled-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 196 Pages
SKU # APRC20278350

Description

Summary

According to APO Research, The global Nifedipine Controlled-release Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nifedipine Controlled-release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nifedipine Controlled-release Tablets include Simcere, Shanghai Shyndec Pharma, Qingdao Baiyang Pharmaceutical, China Resources Double Crane Limin Pharmaceutical (Jinan), Hefei Cube Pharma, Bayer, Nanjing EASEHEAL Pharma, Deyao Pharma and Beijing Honglin Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nifedipine Controlled-release Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nifedipine Controlled-release Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Nifedipine Controlled-release Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nifedipine Controlled-release Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Nifedipine Controlled-release Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Nifedipine Controlled-release Tablets sales, projected growth trends, production technology, application and end-user industry.

Nifedipine Controlled-release Tablets Segment by Company

Simcere
Shanghai Shyndec Pharma
Qingdao Baiyang Pharmaceutical
China Resources Double Crane Limin Pharmaceutical (Jinan)
Hefei Cube Pharma
Bayer
Nanjing EASEHEAL Pharma
Deyao Pharma
Beijing Honglin Pharma
Apichope
Nifedipine Controlled-release Tablets Segment by Type

Generic Drug
Original Drug
Nifedipine Controlled-release Tablets Segment by Application

Hospital and Clinic
Retail Pharmacies
Other
Nifedipine Controlled-release Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine Controlled-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nifedipine Controlled-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine Controlled-release Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nifedipine Controlled-release Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nifedipine Controlled-release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nifedipine Controlled-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Nifedipine Controlled-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Nifedipine Controlled-release Tablets Market Size, 2020 VS 2024 VS 2031
1.3 Global Nifedipine Controlled-release Tablets Market Size Estimates and Forecasts (2020-2031)
1.4 Global Nifedipine Controlled-release Tablets Sales Estimates and Forecasts (2020-2031)
1.5 Global Nifedipine Controlled-release Tablets Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Nifedipine Controlled-release Tablets Market Dynamics
2.1 Nifedipine Controlled-release Tablets Industry Trends
2.2 Nifedipine Controlled-release Tablets Industry Drivers
2.3 Nifedipine Controlled-release Tablets Industry Opportunities and Challenges
2.4 Nifedipine Controlled-release Tablets Industry Restraints
3 Nifedipine Controlled-release Tablets Market by Manufacturers
3.1 Global Nifedipine Controlled-release Tablets Revenue by Manufacturers (2020-2025)
3.2 Global Nifedipine Controlled-release Tablets Sales by Manufacturers (2020-2025)
3.3 Global Nifedipine Controlled-release Tablets Average Sales Price by Manufacturers (2020-2025)
3.4 Global Nifedipine Controlled-release Tablets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Nifedipine Controlled-release Tablets Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Nifedipine Controlled-release Tablets Manufacturers, Product Type & Application
3.7 Global Nifedipine Controlled-release Tablets Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Nifedipine Controlled-release Tablets Market CR5 and HHI
3.8.2 Global Top 5 and 10 Nifedipine Controlled-release Tablets Players Market Share by Revenue in 2024
3.8.3 2024 Nifedipine Controlled-release Tablets Tier 1, Tier 2, and Tier 3
4 Nifedipine Controlled-release Tablets Market by Type
4.1 Nifedipine Controlled-release Tablets Type Introduction
4.1.1 Generic Drug
4.1.2 Original Drug
4.2 Global Nifedipine Controlled-release Tablets Sales by Type
4.2.1 Global Nifedipine Controlled-release Tablets Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Nifedipine Controlled-release Tablets Sales by Type (2020-2031)
4.2.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Type (2020-2031)
4.3 Global Nifedipine Controlled-release Tablets Revenue by Type
4.3.1 Global Nifedipine Controlled-release Tablets Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Nifedipine Controlled-release Tablets Revenue by Type (2020-2031)
4.3.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Type (2020-2031)
5 Nifedipine Controlled-release Tablets Market by Application
5.1 Nifedipine Controlled-release Tablets Application Introduction
5.1.1 Hospital and Clinic
5.1.2 Retail Pharmacies
5.1.3 Other
5.2 Global Nifedipine Controlled-release Tablets Sales by Application
5.2.1 Global Nifedipine Controlled-release Tablets Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Nifedipine Controlled-release Tablets Sales by Application (2020-2031)
5.2.3 Global Nifedipine Controlled-release Tablets Sales Market Share by Application (2020-2031)
5.3 Global Nifedipine Controlled-release Tablets Revenue by Application
5.3.1 Global Nifedipine Controlled-release Tablets Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Nifedipine Controlled-release Tablets Revenue by Application (2020-2031)
5.3.3 Global Nifedipine Controlled-release Tablets Revenue Market Share by Application (2020-2031)
6 Global Nifedipine Controlled-release Tablets Sales by Region
6.1 Global Nifedipine Controlled-release Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Nifedipine Controlled-release Tablets Sales by Region (2020-2031)
6.2.1 Global Nifedipine Controlled-release Tablets Sales by Region (2020-2025)
6.2.2 Global Nifedipine Controlled-release Tablets Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Nifedipine Controlled-release Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Nifedipine Controlled-release Tablets Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Nifedipine Controlled-release Tablets Revenue by Region
7.1 Global Nifedipine Controlled-release Tablets Revenue by Region
7.1.1 Global Nifedipine Controlled-release Tablets Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Nifedipine Controlled-release Tablets Revenue by Region (2020-2025)
7.1.3 Global Nifedipine Controlled-release Tablets Revenue by Region (2026-2031)
7.1.4 Global Nifedipine Controlled-release Tablets Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Nifedipine Controlled-release Tablets Revenue (2020-2031)
7.2.2 North America Nifedipine Controlled-release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Nifedipine Controlled-release Tablets Revenue (2020-2031)
7.3.2 Europe Nifedipine Controlled-release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Nifedipine Controlled-release Tablets Revenue (2020-2031)
7.4.2 Asia-Pacific Nifedipine Controlled-release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Nifedipine Controlled-release Tablets Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Nifedipine Controlled-release Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Simcere
8.1.1 Simcere Comapny Information
8.1.2 Simcere Business Overview
8.1.3 Simcere Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Simcere Nifedipine Controlled-release Tablets Product Portfolio
8.1.5 Simcere Recent Developments
8.2 Shanghai Shyndec Pharma
8.2.1 Shanghai Shyndec Pharma Comapny Information
8.2.2 Shanghai Shyndec Pharma Business Overview
8.2.3 Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Product Portfolio
8.2.5 Shanghai Shyndec Pharma Recent Developments
8.3 Qingdao Baiyang Pharmaceutical
8.3.1 Qingdao Baiyang Pharmaceutical Comapny Information
8.3.2 Qingdao Baiyang Pharmaceutical Business Overview
8.3.3 Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
8.3.5 Qingdao Baiyang Pharmaceutical Recent Developments
8.4 China Resources Double Crane Limin Pharmaceutical (Jinan)
8.4.1 China Resources Double Crane Limin Pharmaceutical (Jinan) Comapny Information
8.4.2 China Resources Double Crane Limin Pharmaceutical (Jinan) Business Overview
8.4.3 China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Product Portfolio
8.4.5 China Resources Double Crane Limin Pharmaceutical (Jinan) Recent Developments
8.5 Hefei Cube Pharma
8.5.1 Hefei Cube Pharma Comapny Information
8.5.2 Hefei Cube Pharma Business Overview
8.5.3 Hefei Cube Pharma Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Hefei Cube Pharma Nifedipine Controlled-release Tablets Product Portfolio
8.5.5 Hefei Cube Pharma Recent Developments
8.6 Bayer
8.6.1 Bayer Comapny Information
8.6.2 Bayer Business Overview
8.6.3 Bayer Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Bayer Nifedipine Controlled-release Tablets Product Portfolio
8.6.5 Bayer Recent Developments
8.7 Nanjing EASEHEAL Pharma
8.7.1 Nanjing EASEHEAL Pharma Comapny Information
8.7.2 Nanjing EASEHEAL Pharma Business Overview
8.7.3 Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Product Portfolio
8.7.5 Nanjing EASEHEAL Pharma Recent Developments
8.8 Deyao Pharma
8.8.1 Deyao Pharma Comapny Information
8.8.2 Deyao Pharma Business Overview
8.8.3 Deyao Pharma Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Deyao Pharma Nifedipine Controlled-release Tablets Product Portfolio
8.8.5 Deyao Pharma Recent Developments
8.9 Beijing Honglin Pharma
8.9.1 Beijing Honglin Pharma Comapny Information
8.9.2 Beijing Honglin Pharma Business Overview
8.9.3 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product Portfolio
8.9.5 Beijing Honglin Pharma Recent Developments
8.10 Apichope
8.10.1 Apichope Comapny Information
8.10.2 Apichope Business Overview
8.10.3 Apichope Nifedipine Controlled-release Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Apichope Nifedipine Controlled-release Tablets Product Portfolio
8.10.5 Apichope Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Nifedipine Controlled-release Tablets Value Chain Analysis
9.1.1 Nifedipine Controlled-release Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Nifedipine Controlled-release Tablets Production Mode & Process
9.2 Nifedipine Controlled-release Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Nifedipine Controlled-release Tablets Distributors
9.2.3 Nifedipine Controlled-release Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.